Medicine Research Conference returns 10/29

By Anton Zuiker
The Department of Medicine is relaunching the Research Conference, an important event for promoting collaboration within our research community and providing our junior faculty an opportunity for cross-discipline feedback and mentoring. Starting October 29th, the Medicine Research Conference will take place at noon on the final Friday of each month (with a few exceptions; see schedule below). It is expected that all faculty participating in basic and clinical research in the Department of Medicine will make every effort to attend. CME credit will be given and lunch will be provided. Speakers have been nominated by division chiefs for the honor of presenting in this inaugural year. The format will be two half-hour presentations with adequate time for questions. The speakers and topics for the first conference – Fri., Oct. 29 at 12 noon in DN 2002 – are:
“Genetics and Genomics of Susceptibility to Staphylococcus aureus” Vance Fowler, MD, MHS Associate Professor of Medicine Division of Infectious Diseases and International Health "Host Response as a Diagnostic and Predictive Tool for Infectious Diseases: Moving Towards Clinical Utility" Aimee K. Zaas, MD, MHS Assistant Professor of Medicine Division of Infectious Diseases and International Health
The schedule for the rest of the academic year, with some adjustments for the holiday season, is as follows:
  • November 19th
  • January 28th
  • February 25th
  • March 25th
  • April 29th
  • May 27th
  • June 24th
Please mark your calendars for these dates, and thank you in advance for your support of this important education endeavor. UPDATE: Watch video below (click on the exploding arrows in the volume bar to view fullscreen):  

Vance Fowler, MD, MHS, associate professor of medicine (Infectious Diseases) presents Genetics and Genomics of Susceptibility to Staphylococcus aureus” and Aimee K. Zaas, MD, MHS, assistant professor of medicine (Infectious Diseases) presents "Host Response as a Diagnostic and Predictive Tool for Infectious Diseases: Moving Towards Clinical Utility."

Share